Competitive Technologies' Calmare(R) Therapy Medical Device Treating Cancer Patients in Texas


FAIRFIELD, Conn., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced that McKinney Regional Cancer Care Center, a private physician oncology practice based in McKinney, TX, is the first cancer center in Texas treating with CTT's Calmare® Pain Therapy Treatment medical device. Patients suffering from pain related to cancer are being treated under the direction of medical oncologist Dennis Birenbaum, M.D.

"We are excited to have McKinney Regional Cancer Care Center, with locations in the Dallas/Ft. Worth area, evaluating our Calmare Therapy Treatment device," said John B. Nano, CTT's Chairman, President, and CEO. "We are all committed to improving cancer patients' quality of life. We know that our Calmare device is the only highly effective treatment for chemotherapy-induced peripheral neuropathy (CIPN) without the harmful, adverse side effects of narcotic pain killers. From the growing body of evidence-based patient outcomes we know that in addition to CIPN, our Calmare device successfully treats chronic neuropathic pain resulting from cancer, cancer chemotherapy, phantom limb syndrome, failed back surgery, sciatica, spinal stenosis, shingles and other maladies." 

"We are pleased to offer this treatment option for our patients who suffer from severe and intractable pain," said McKinney Regional Cancer Care's Dr. Birenbaum. "Suffering from cancer and other diseases is difficult enough. We are already seeing the benefit to patients from using the Calmare pain therapy device. It is rewarding to administer and observe this new and effective pain treatment helping our patients avoid the negative side effects of narcotic painkillers and improve their quality of life."

The non-invasive Calmare pain therapy device uses the biophysical "Scrambler Therapy" technology, which was developed in Italy by CTT's client, Professor Giuseppe Marineo. CTT's partner, GEOMC Co. Ltd. of Seoul, Korea is manufacturing the Calmare device, which has U.S. FDA clearance and European Union CE Mark clearance for sales. For more information about Calmare Pain Therapy Treatment, visit www.CalmareTT.com.

About McKinney Regional Cancer Care Center (MRCC)

McKinney Regional Cancer Care Center (MRCC) is a leading edge, outpatient diagnosis and treatment facility in Carrollton, Texas. Along with affiliated clinics MRCC's goals are to eliminate cancer and improve the quality of life in patients undergoing cancer treatment. To MRCC's physicians and staff, people are more than just their cancer symptoms and treatments. They combine compassion with aggressive treatment to provide patients with treatment, diagnostic and support services in a collaborative environment that is focused on patient care.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net

Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2009, filed with the SEC on October 27, 2009, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.



            

Contact Data